GLOBAL HEMP GROUP INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.045 CAD | -25.00% |
|
-10.00% | -30.77% |
| Jan. 16 | Global Hemp Group Inc. cancelled the transaction announced on January 15, 2024 | CI |
| Jan. 15 | Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding | CI |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 5.04M 6.93M |
|---|---|---|---|---|---|
| Net income 2021 | -8M -11.01M | Net income 2022 | -2M -2.75M | EV / Sales 2021 | - |
| Net Debt 2021 | 4.06M 5.59M | Net Debt 2022 | 2.89M 3.98M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-1.16
x | P/E ratio 2022 |
-2.15
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -25.00% | ||
| 1 week | -10.00% | ||
| Current month | -10.00% | ||
| 1 month | -25.00% | ||
| 3 months | -25.00% | ||
| 6 months | +50.00% | ||
| Current year | -30.77% |
1 week
0.05
0.06
1 month
0.050.06
Current year
0.050.12
1 year
0.020.30
3 years
0.022.20
5 years
0.022.20
10 years
0.027.80
| Managers | Title | Age | Since |
|---|---|---|---|
Curtis Huber
CEO | Chief Executive Officer | - | 14-11-16 |
| Chief Tech/Sci/R&D Officer | 64 | - | |
Michel Lebeuf
SEC | Corporate Secretary | 50 | 20-05-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Curtis Huber
CEO | Chief Executive Officer | - | 14-11-16 |
| Director/Board Member | - | 23-02-13 | |
Michel Lebeuf
SEC | Corporate Secretary | 50 | 20-05-20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 0.045 | 0.00% | 15,500 |
| 24-04-15 | 0.045 | -25.00% | 15,500 |
Delayed Quote Canadian Securities Exchange, April 15, 2024 at 03:57 pm EDT
More quotes
Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Companyâs has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.
Calendar
2024-05-27
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.77% | 795K | |
| +39.92% | 272M | |
| +34.02% | 276M | |
| -31.48% | 141M | |
| +46.52% | 133M | |
| +100.82% | 112M | |
| -42.86% | 96.23M | |
| +7.69% | 93.09M | |
| +150.00% | 75.33M | |
| +37.50% | 63.28M |
- Stock Market
- Equities
- GHG Stock
